Palisades Fire Victims Sue City of Los Angeles for Failure to “Inspect, Maintain, and Operate” Water System “Cost-Saving” Measure Led to Empty Reservoir and Catastrophic Consequences
GlobeNewswire· 2025-01-24 00:45
LOS ANGELES, Jan. 23, 2025 (GLOBE NEWSWIRE) -- Pacific Palisades homeowners Spencer and Heidi Pratt along with other fire victims have filed suit today in the Los Angeles Superior Court against the City of Los Angeles for the City’s failure “to properly construct, inspect, maintain and operate its water supply system” that led to the destruction of their home by the Palisades Fire. “The Palisades Fire was an inescapable and unavoidable consequence of the egregious failure of the water supply system servicin ...
ROSEN, NATIONAL INVESTOR COUNSEL, Encourages Symbotic Inc. Investors to Secure Counsel Before Important February 3 Deadline in Securities Class Action First Filed by the Firm – SYM
GlobeNewswire· 2025-01-24 00:45
NEW YORK, Jan. 23, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Symbotic Inc. (NASDAQ: SYM) between February 8, 2024 and November 26, 2024, both dates inclusive (the “Class Period”), of the important February 3, 2025 lead plaintiff deadline in the securities class action first filed by the Firm. SO WHAT: If you purchased Symbotic securities during the Class Period you may be entitled to compensation without payment of any out of pocket ...
Here's What Key Metrics Tell Us About First Financial (FFBC) Q4 Earnings
ZACKS· 2025-01-24 00:31
For the quarter ended December 2024, First Financial Bancorp (FFBC) reported revenue of $225.53 million, up 11.4% over the same period last year. EPS came in at $0.71, compared to $0.62 in the year-ago quarter.The reported revenue represents a surprise of +5.04% over the Zacks Consensus Estimate of $214.7 million. With the consensus EPS estimate being $0.65, the EPS surprise was +9.23%.While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to ...
Associated Banc-Corp (ASB) Reports Q4 Earnings: What Key Metrics Have to Say
ZACKS· 2025-01-24 00:31
Associated Banc-Corp (ASB) reported $345.78 million in revenue for the quarter ended December 2024, representing a year-over-year increase of 7.3%. EPS of $0.57 for the same period compares to $0.53 a year ago.The reported revenue compares to the Zacks Consensus Estimate of $343.34 million, representing a surprise of +0.71%. The company delivered an EPS surprise of +3.64%, with the consensus EPS estimate being $0.55.While investors closely watch year-over-year changes in headline numbers -- revenue and earn ...
Compared to Estimates, Business First (BFST) Q4 Earnings: A Look at Key Metrics
ZACKS· 2025-01-24 00:31
For the quarter ended December 2024, Business First (BFST) reported revenue of $77.59 million, up 28.9% over the same period last year. EPS came in at $0.66, compared to $0.66 in the year-ago quarter.The reported revenue represents a surprise of +2.90% over the Zacks Consensus Estimate of $75.4 million. With the consensus EPS estimate being $0.46, the EPS surprise was +43.48%.While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Stre ...
Compared to Estimates, Midland States Bancorp (MSBI) Q4 Earnings: A Look at Key Metrics
ZACKS· 2025-01-24 00:31
For the quarter ended December 2024, Midland States Bancorp (MSBI) reported revenue of $75.6 million, down 3.8% over the same period last year. EPS came in at -$2.52, compared to $0.89 in the year-ago quarter.The reported revenue represents a surprise of +2.36% over the Zacks Consensus Estimate of $73.85 million. With the consensus EPS estimate being $0.70, the EPS surprise was -460.00%.While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations ...
MidWestOne (MOFG) Reports Q4 Earnings: What Key Metrics Have to Say
ZACKS· 2025-01-24 00:31
MidWestOne (MOFG) reported $59.78 million in revenue for the quarter ended December 2024, representing a year-over-year increase of 64.1%. EPS of $0.77 for the same period compares to $0.51 a year ago.The reported revenue represents a surprise of +6.61% over the Zacks Consensus Estimate of $56.07 million. With the consensus EPS estimate being $0.72, the EPS surprise was +6.94%.While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determi ...
OceanFirst (OCFC) Q4 Earnings: How Key Metrics Compare to Wall Street Estimates
ZACKS· 2025-01-24 00:31
OceanFirst Financial (OCFC) reported $95.56 million in revenue for the quarter ended December 2024, representing a year-over-year decline of 4.1%. EPS of $0.38 for the same period compares to $0.45 a year ago.The reported revenue compares to the Zacks Consensus Estimate of $95.7 million, representing a surprise of -0.15%. The company delivered an EPS surprise of +5.56%, with the consensus EPS estimate being $0.36.While investors closely watch year-over-year changes in headline numbers -- revenue and earning ...
Glacier Bancorp (GBCI) Reports Q4 Earnings: What Key Metrics Have to Say
ZACKS· 2025-01-24 00:31
Glacier Bancorp (GBCI) reported $222.99 million in revenue for the quarter ended December 2024, representing a year-over-year increase of 13%. EPS of $0.54 for the same period compares to $0.49 a year ago.The reported revenue compares to the Zacks Consensus Estimate of $221.85 million, representing a surprise of +0.52%. The company delivered an EPS surprise of +1.89%, with the consensus EPS estimate being $0.53.While investors closely watch year-over-year changes in headline numbers -- revenue and earnings ...
Hip and Knee Reconstructive Market to Reach USD 41,071.4 Million by 2035, Growing at a 5.6% CAGR from 2025 to 2035 | FMI
GlobeNewswire· 2025-01-24 00:30
Market Overview - The hip and knee reconstructive market is projected to grow from USD 23,880.2 million in 2025 to USD 41,071.4 million by 2035, with a CAGR of 5.6% [1][2] - Key drivers include the rising prevalence of osteoarthritis, an aging population, and technological advancements in surgical techniques and implants [2][3][4] Key Growth Drivers - Increasing prevalence of osteoarthritis: Nearly 10% of men and 18% of women over 60 suffer from symptomatic osteoarthritis, driving demand for reconstructive surgeries [3][6] - Aging population: The global aging demographic significantly contributes to the demand for joint reconstruction surgeries, particularly among those aged 70 and older [7][12][13] - High obesity rates: Rising obesity rates globally are linked to joint problems, increasing the need for reconstructive surgeries [8][33] - Technological advancements: Innovations such as robotics-assisted surgeries, 3D-printed implants, and minimally invasive techniques are improving surgical precision and patient outcomes [4][10][16] Technological Trends - Robotics-assisted surgeries and AI integration are dominating innovation in the market [5][10] - 3D printing is redefining the landscape by offering patient-specific implants and enhanced precision [4][10] - Smart implants with real-time data tracking and augmented reality (AR) in surgical planning are emerging trends [45][50] Regional Insights - North America leads the market with over 40% share, driven by advanced healthcare infrastructure and high adoption of cutting-edge technologies [17][50] - Asia-Pacific shows the highest growth potential, with countries like China and India experiencing rapid market expansion due to increasing healthcare investments [17][50] - Europe holds the second-largest market share, supported by aging demographics and government-funded healthcare systems [50] Market Segmentation - By product: The market is divided into hip reconstruction (partial and revision implants) and knee reconstruction (total and partial implants) [24] - By fixation: Segmented into cement, cementless, and hybrid [24] - By end user: Includes hospitals, orthopedic clinics, and ambulatory surgical centers [24] Key Players - Major companies in the industry include Zimmer Biomet, Smith & Nephew plc, Stryker, Johnson & Johnson, and MicroPort Scientific Corporation [26][50] Future Outlook - The market is poised for transformative growth, with patient-specific implants and minimally invasive techniques redefining standard care practices [17][42] - Companies focusing on affordability alongside innovation are expected to gain a competitive edge [17][42]